ECC5004

· Eccogene

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ECC5004, covering 2024-07-17 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants [Phase 1]